Global Cannabis Testing Market Projected to Grow At A CAGR OF 16.5%

 

Cannabis Testing Market Key Highlights

 

  - In 2025, the cannabis testing market size was valued at US$ 2.1 billion
  - The cannabis testing market is expected to reach US$ 9.67 billion by 2035
  - The market is anticipated to grow at a CAGR of 16.5% in the coming decade;
  - Based on Type, the potency testing segment accounting for the highest market share.
  - Based on application, the laboratories segment accounting for the highest market share.
  - In terms of region, the North America cannabis testing market held the dominant share in 2025.

 

 

Global Cannabis Testing Market Overview:

 

The global market for cannabis testing was valued at USD 2.1 bn in 2025, reflecting a CAGR of 16.5% from 2026 to 2035. It is projected to grow to USD 9.67 bn by 2035. In the recent years, cannabidiol (CBD) has become immensely popular around the world. CBD is used to treat a wide range of medical conditions and lifestyle diseases such as, Dravet syndrome in children. Although, the growing availability of CBD, many doubts remain about the legality, quality, and safety of this new cure. The central question is whether CBD is simply a food supplement, an investigational new medicine, or a narcotic. As a result, CBD is under scrutiny on many levels, ranging from national health organizations and agricultural lobbyists to the WHO and FDA.

 

CBD had a therapeutic effect on a serious form of epilepsy in children, called Dravet syndrome. This effect is now under clinical investigation with the pharmaceutical CBD product Epidiolex, which is currently in phase III trials with encouraging results. Although, research into the therapeutic effects of CBD is rapidly increasing, most current uses of CBD are not supported by clinical data. Despite, these popular products have wide variety of usage, the physicians confronted with the effects of CBD oil even when they do not prescribe it themselves. The main difference is that medicinal drugs are considered unsafe until proven safe, whereas food supplements are considered safe until proven otherwise. In result, the central question becomes whether or not CBD is safe for consumers (children, elderly, and patients) in large and unregulated quantities. However, the risks to be evaluated about CBD products not have the pure compound CBD itself, but more with the unknown composition and quality of the products offered. This leads to several harmful substances such as, leading to severe health issues or hospitalization.

 

The lack of knowledge of real risks at various levels, from single microbial isolate cultures through human population measurements and impure nature of CBD oil can hamper the growth of the cannabis testing market in the forecast period.

 

Besides, the advances cannabis testing and services are enabling to drive the industry and accelerate growth in drug development and medicine as well as regulatory guidance. The medicinal cannabis industries is growing at rapid pace, and is expected to witness tremendous growth by 2025. The approval for cannabis usage and for some startups can be a trend in the region. For instance, in 2017, medical marijuana was only legalized In Germany, while the UK just received its first batch of medical cannabis. In Spain, marijuana is basically decriminalized (though enforcement depends on the province). Moreover, the country is also known as a home to various cannabis clubs, though many are under threat of shutdown.

 

This report provide an overview of the global cannabis testing industry, including market size, historic market revenue, sales data, value chain analysis, market segmentation by type, by application, by region, key growth drivers and its competitive landscape. Also, it analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2035. Evaluation and forecast the market size for cannabis testing sales, projected growth trends, production technology, application and end-user industry. Within the type segment, the potency testing is the fastest growing sub-segment. The potency testing segment accounted for the largest market share of _% in 2025, with a market value of USD _ Billion and is projected to grow at the highest CAGR of _% during the forecast period. This growth is driven by regulatory mandates requiring accurate labelling of THC, CBD, and other cannabinoids. Accurate potency testing ensures consumer safety and supports product standardization, which is crucial for both medical and recreational cannabis markets. Without verified potency results from an approved laboratory, products cannot be legally distributed. This ensures consumers receive accurate dosage information and prevents overconsumption or mislabeling.. The Pesticide Screening Testing segment was the second-largest market in 2025, valued at USD _ Million in 2025; it is projected to grow at a CAGR of _% during the forecast period. In the application segment, the laboratories segment is the fastest-growing segment. The laboratories segment is accounted for the largest market share of _% in 2025, with a market value of USD _ Billion and is projected to grow at the highest CAGR of _% during the forecast period.

 

This cannabis testing market report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2035.

 

Cannabis Testing Market Segmentation:

 

Market Segment By Type:

 

Type-wise breakup of the global cannabis testing market

 

    Terpene Profiling Testing
    Heavy Metal Testing
    Microbial Analysis Testing
    Genetic Testing
    Residual Solvent Screening Testing
    Potency Testing
    Pesticide Screening Testing

 

Based on Type, the cannabis testing market is divided into terpene profiling testing, heavy metal testing, microbial analysis testing, genetic testing, residual solvent screening testing, potency testing, pesticide screening testing. The potency testing segment recorded a significant revenue share in the cannabis testing market in 2025.

 

By Application:

 

Application-wise breakup of the global cannabis testing market

 

    Laboratories
    Research Institutions
    Others

 

Based on application, the cannabis testing market is divided into laboratories, research institutions, others, . The laboratories segment recorded a significant revenue share in the cannabis testing market in 2025.

 

Cannabis Testing Market: Geographic Analysis

 

The regional analysis of the cannabis testing market provides valuable insights into the geographical distribution of market trends, opportunities, and challenges across different regions. According to the latest cannabis testing market trends, North America held the largest share in 2025. This dominance is attributed to several factors fueling demand in the region. Asia Pacific is projected to be the fastest growing region in the global market.

The cannabis testing market is segmented on the basis of geography into:

    North America
    Europe
    Asia Pacific
    Latin America
    Middle East & Africa

 

Competitive Landscape

 

The global cannabis testing market is highly fragmented with the presence of large number of players globally. Some of the major companies include, Agilent Technologies, Inc., SHIMADZU CORPORATION, MERCK KGaA, Digipath Inc., Accelerated Technology Laboratories, Inc., CannaSafe Analytics, WATERS, Restek Corporation, Sciex, PerkinElmer, Inc.

 

Company Profiles:

 

Major companies operating in the cannabis testing market:

Agilent Technologies, Inc., SHIMADZU CORPORATION, MERCK KGaA, Digipath Inc., Accelerated Technology Laboratories, Inc., CannaSafe Analytics, WATERS, Restek Corporation, Sciex, PerkinElmer, Inc.

 

Cannabis Testing Market Scope

 

Report Attribute	Details
Report Objective	To provide comprehensive insights into the cannabis testing market size, trends, segmentation, regional dynamics, and competitive landscape.
Base Year	2025
Historical Period	2020–2024
Forecast Period	2025–2033
Market Size In 2025	USD 2.1 Billion
Market Size In 2035	USD 9.67 Billion
Compound Annual Growth Rate (CAGR)	16.5%
Segments	By Product Type   Terpene Profiling Testing, Heavy Metal Testing, Microbial Analysis Testing, Genetic Testing, Residual Solvent Screening Testing, Potency Testing, Pesticide Screening Testing   By Application   Laboratories, Research Institutions, Others,
Regions Covered	North America Asia-Pacific Europe South America Middle East and Africa
Companies Profiled	Agilent Technologies, Inc., SHIMADZU CORPORATION, MERCK KGaA, Digipath Inc., Accelerated Technology Laboratories, Inc., CannaSafe Analytics, WATERS, Restek Corporation, Sciex, PerkinElmer, Inc.